Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Susmita Roy

Mpharm (Pharmacology)

Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

Home

Susmita Roy

Articles By : Susmita Roy

Novo Nordisk gets UK nod for Concizumab to prevent bleeding episodes frequency

Novo Nordisk's Wegovy, Fiasp, Ryzodeg Injectables Stolen During Transit, DCGI Issues Alert

Susmita Roy23 Aug 2025 3:00 PM IST

New Delhi: The Drugs Controller General of India (DCGI) has issued an alert for doctors and healthcare professionals to carefully prescribe and...

SEC Asks Enzene Biosciences to Revise Phase III Trial Protocol for Nivolumab Biosimilar

Drugs and Cosmetics Act Set for Fresh Decriminalization Under Jan Vishwas Bill 2025

Susmita Roy21 Aug 2025 7:16 PM IST

New Delhi: The Drugs and Cosmetics Act, 1940, key legislation governing India's pharmaceutical sector, is set for further decriminalization under the...

Emcure Pharma Gets CDSCO Panel Nod to Conduct Phase IV Trial on Drospirenone Tablets

CDSCO Panel Approves Emcure's Phase III Clinical Trial of Semaglutide, Mandates Govt Trial Sites

Susmita Roy21 Aug 2025 6:53 PM IST

New Delhi: Accepting the bioequivalence (BE) study report, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...

Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma

Susmita Roy20 Aug 2025 4:20 PM IST

New Delhi: Following a thorough discussion on the proposed Phase III clinical trial protocol for roflumilast cream, the Subject Expert Committee (SEC)...

Emcure Pharma confirms GST search, assures No Material Impact on operations

Illegal Alprazolam Unit Busted in Andhra, 8 Arrested, Drugs Worth Rs 24 Crore Seized

Susmita Roy20 Aug 2025 3:58 PM IST

New Delhi: In a major crackdown on the illegal drug trade, the Directorate of Revenue Intelligence (DRI) has discovered a clandestine manufacturing...

Sun Pharma Asked to Resubmit Revised Phase III Protocol for Delafloxacin CABP Trial

Sun Pharma's Dapagliflozin, Glimepiride, Metformin FDC Fails to Secure CDSCO Panel Nod Over Safety, Utility Concerns

Susmita Roy19 Aug 2025 3:11 PM IST

New Delhi: Expressing doubts over the clinical utility of administering such a small dose of Glimepiride once daily, especially considering over the...

CDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof Cream

Submit BE Raw Data, Interaction Study on Dapagliflozin-Rosuvastatin FDC: Expert Panel Tells Pure and Cure

Susmita Roy19 Aug 2025 3:02 PM IST

New Delhi: In line with the proposal presented by Pure and Cure Healthcare for the Dapagliflozin plus Rosuvastatin film-coated tablet, the Subject...

Bayer begins Phase IIa trial of BAY 3401016 for Alport Syndrome

Bayer Gets CDSCO Committee Nod to Manufacture, Market Darolutamide 300 mg for mHSPC, PMS Study Mandated

Susmita Roy18 Aug 2025 2:00 PM IST

New Delhi: Bayer Pharmaceuticals has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...

CDSCO Launches Online Risk Classification Module for Non-IVD Medical Devices

Imported Devices Face 7.5-10% Duty, Domestic Devices GST at 12%, Govt Clarifies

Susmita Roy17 Aug 2025 4:00 PM IST

New Delhi: While imported medical devices attract a basic customs duty of 7.5-10% along with a 5% health cess, domestically manufactured medical...

Dr Reddys Labs secures European Commission approval for biosimilar to treat osteoporosis

Dr Reddy's Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML

Susmita Roy17 Aug 2025 4:00 PM IST

New Delhi: In a significant development, the pharmaceutical major, Dr. Reddy's Laboratories, has got the go-ahead from the Subject Expert Committee...

Sun Pharma Gets CDSCO Panel Nod for Active PMS of Fexuprazan Hydrochloride Tablets

Susmita Roy15 Aug 2025 2:31 PM IST

New Delhi: Sun Pharma Laboratories has got the go-ahead from the Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control...

Chemists' Body Warns of 55% Rise in Drug Abuse, Calls for Ban on 10-Minute Prescription Drug Delivery

Susmita Roy15 Aug 2025 11:30 AM IST

New Delhi: Speaking up against a worrying circumstance, the All India Organisation of Chemists and Druggists (AIOCD), representing over 12.40 lakh...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok